Invention Application
- Patent Title: CRYSTALLINE COMPOSITION OF TILDACERFONT AND METHODS OF USE AND PREPARATION THEREOF
-
Application No.: PCT/US2022/050436Application Date: 2022-11-18
-
Publication No.: WO2023091684A1Publication Date: 2023-05-25
- Inventor: REDDY, Dasharatha , RAJAGOPAL, Ashokraj , WANG, Lu , BARNES, Christopher
- Applicant: SPRUCE BIOSCIENCES, INC.
- Applicant Address: 611 Gateway Boulevard
- Assignee: SPRUCE BIOSCIENCES, INC.
- Current Assignee: SPRUCE BIOSCIENCES, INC.
- Current Assignee Address: 611 Gateway Boulevard
- Agency: OLSHEMSKI, Stephen
- Priority: US63/281,462 2021-11-19
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/5377 ; A61K47/12 ; A61K9/00 ; A61P5/38 ; A61P15/08 ; A61P5/24
Abstract:
Described herein are crystalline composition, methods of making such crystalline composition, pharmaceutical compositions and medicaments comprising such crystalline composition, and methods of using such crystalline composition in the treatment of conditions, diseases, or disorders that would benefit from modulation of Corticotropin-releasing hormone receptor 1 (CRF1).
Information query
